血管紧张素受体AT_2和AT_4研究进展.pdfVIP

# 58# 2010 31 1 A dv Card iovasc D is, Jan ary 2010, Vol. 31, N o. 1 [ 8] Rump LC. Secondary rise of album inuria under AT -receptor blockade) w at is [ 15] C apman N, D obson J,W ilson S, et al. Effect of spironolactone on b lood pres- 1 t e potent ial role of aldosterone escape[ J]. Nep rol D ial T ransplant, 2007, 22 sure ni subjects w it resistant ypertension [ J] . H ypertension, 2007, 49( 4) : ( 1) : 5-8. 839-845. [ 9] M orris DJ, Lat if SA, Brem A S. Interactions of m ineralocort icoids and glucocorti- [ 16] K rum H, N olly H,W orkman D, et a.l Efficacy of eplerenone added to renin-an- coids in epit elial target tissues revis ited[ J] . Steroids, 2009, 74( 1) : 1-6. giotensin b lockade in ypertensive patients[ J]. Hypertens ion, 2002, 40: 117- [ 10] Pmi enta E, Cal oun DA, Oparil S. Sleep apea, aldosterone, and resistant yper- 123. tens ion[ J] . Prog CardiovascD is, 2009, 51( 5) : 371-380. [ 17] W einbergerMH, W iteWB, Ru ilope LM, et a.l Effects of eplerenone versus [ 11] Strut ersA, K rum H, W illiam s GH. A comparison of t e aldosterone-blocking losartan in patientsw it low-renin ypertension[ J]. Am H eart J, 2005, 150: agents eplerenone and spironolactone[ J] . C lni Cardio,l 2008, 31(4) : 153-158. 426-433. [ 12] Ouzan J, Perault C, Lincoff AM, et al. T e role of spironolactone in t e treat- [ 18] T rewet CL, ErnstM E. R esistan t ypertension: ident ifying causes and optmi izing ment of patientsw it refractory ypertension[ J]. Am J Hypertens, 2002, 15( 4 treatment regmi es[ J]. Sout M ed J, 2008, 101(2) : 166-173. pt 1) : 333-339. [ 19] Strut ersAD. A ldosterone b lockade in cardiovascular disease[ J]. Heart, 2004, [ 13